Promising results for new quality of vision metric

Article

It is mandatory to develop precise , reproducible and accurate methodologies to obtain objective measurements of quality of vision, namely night vision, in order to create surgical techniques that will eliminate post-refractive vision disturbances, Joachim Murta said.

It is mandatory to develop precise , reproducible and accurate methodologies to obtain objective measurements of quality of vision, namely night vision, in order to create surgical techniques that will eliminate post-refractive vision disturbances, Joachim Murta said.

He added that a study conducted with a new quality of vision metric showed promising results.

Dr Murta of the University Hospital Coimbra, Portugal, performed a prospective study to evaluate the quality of vision in patients undergoing LASIK with either Planoscan or Zyoptix, using a new methodology called Mesopic High Resolution Perimetry. "It uses a frequency doubling technique which is relatively independent of optical factors," said Dr Murta.

The study evaluated contrast sensitivity in patients submitted to LASIK. Mesopic High Resolution Perimetry analysed central vision, while a Optical Quality Analysis System (OQAS) tested peripheral vision.

40 eyes with less than 6 D of myopia and 1.5 D of astigmatism were included. Group I were treated with Planoscan while Group II were treated with Zyoptix. Pre- and postoperative spherical equivalent, mean keratometry, age, OZ, RST, pupil size, aberrometry and subjective rating of night vision complaints were evaluated.

A decreased contrast sensitivity was noted in myopes compared with normal population (p

Dr Murta concluded that the preliminary results obtained are promising for the evaluation of the quality of vision under mesopic conditions.

Ophthalmology Times Europe reporting from the XXIV Congress of the ESCRS, London, 9-13 September, 2006.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.